IDEAYA Biosciences (IDYA) Reports In-Line Q4 EPS
Tweet
Share
E-mailGet Alerts IDYA Hot Sheet
Join SI Premium – FREE
IDEAYA Biosciences (NASDAQ: IDYA) reported Q4 EPS of ($0.94), in-line with the analyst estimate of ($0.94). Revenue for the quarter came in at $10.88 million versus the consensus estimate of $6.12 million.
For earnings history and earnings-related data on IDEAYA Biosciences (IDYA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Microsoft plans data center push to triple its computing power - Bloomberg
- JPMorgan Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
- B.Riley Starts Neuronetics (STIM) at Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
